Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis

Neurology

Volumn 46, Issue 2, 1996, Pages 373-378

  Thorpe, J W ^a   Kidd, D ^a   Moseley, I F ^a   Kendall, B E ^a   Thompson, A J ^a   MacManus, D G ^a   McDonald, W I ^a   Miller, D H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; BRAIN RADIOGRAPHY; CLINICAL ARTICLE; DISEASE ACTIVITY; FEMALE; HUMAN; IMAGE ENHANCEMENT; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELAPSE; REMISSION; SPINAL CORD FUNCTION; THREE DIMENSIONAL IMAGING;

EID: 0029925782     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.2.373     Document Type: Article

References (36)

1. Isaac C, Li DKB, Genton M, et al. Multiple sclerosis: a serial study using MRI in relapsing patients. Neurology 1988;38: 1511-1515.
2. Willoughby EW, Grochowski E, Li DKB, Oger J, Kastrukoff LF, Paty DW. Serial magnetic resonance scanning in patients with multiple sclerosis: a second prospective study in relapsing patients. Ann Neurol 1989;25:43-49.
3. Truyen L, Gheuhens J, Parizel PM, Van den Vyver FL, Martin JJ. Long term follow-up of MS by standardized, non-contrast-enhanced MRI. J Neurol Sci 1991;106:35-40.
4. Bastianello JA, Pozzilli C, Bernardi S, et al. Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis. Neurology 1990;40:591-595.
5. Harris JO, Frank JA, Patronas NJ, McFarlin DF, McFarland HF. Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early relapsing-remitting multiple sclerosis: implications for clinical trials and natural history. Ann Neurol 1991;29:548-555.
6. Miller DH, Rudge P, Johnson G, et al. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain 1988;111:927-939.
7. Thompson AJ, Kermode AG, Wicks D, et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 1991;29:53-62.
8. Barkhof F, Scheltens P, Frequin STFM, et al. Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity. AJR 1992; 159:1041-1047.
9. Capra R, Marciano N, Vignolo LA, Chiesa A, Gasparotti R. Gadolinium-pentetic acid magnetic resonance imaging in patients with relapsing remitting multiple sclerosis. Arch Neurol 1992;49:687-689.
10. McFarland HF, Frank JA, Albert PS, et al. Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol 1992;32:758-766.
11. Stone LA, Smith ME, Albert PS, et al. Blood brain barrier disruption as measured by contrast enhanced MRI in patients with mild relapsing remitting multiple sclerosis: relationship to course, gender and age. Neurology 1995;45:1122-1126.
12. Kappos L, Stadt D, Ratzka M, et al. Magnetic resonance imaging in the evaluation of treatment in multiple sclerosis. Neuroradiology 1988;30:299-302.
13. Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry 1991;54:683-688.
14. Kastrukoff LF, Oger JJF, Hashimoto SA, et al. Systemic lym-phoblastoid interferon therapy in chronic progressive multiple sclerosis. I. Clinical and MRI evaluation. Neurology 1990;40: 479-486.
15. Koopmans RA, Li DKB, Zhoa GJ, Redekop WK, Paty DW. MRI assessment of cyclosporine therapy of MS in a multicenter trial [abstract]. Neurology 1992;42(suppl 3):210.
16. Paty DW, Li DKB, the UBC MS/MRI Study Group, the IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993;43:662-667.
17. Masaryk TJ, Modic MT, Geisenger MA, et al. Cervical myelopathy: a comparison of magnetic resonance and myelography. J Comp Assist Tomogr 1986;10:184-194.
18. Maravilla KR, Weintreb JC, Suss R, Nunally RL. Magnetic resonance demonstration of multiple sclerosis plaques in the cervical cord. AJR 1985;144:381-385.
19. Miller DH, McDonald WI, Blumhardt LD, et al. Magnetic resonance imaging in isolated noncompressive spinal cord syndromes. Ann Neurol 1987;22:714-723.
20. Honig LS, Sheremata WA. Magnetic resonance imaging of spinal cord lesions in multiple sclerosis. J Neurol Neurosurg Psychiatry 1989;52:459-466.
21. Turano G, Jones SJ, Miller DH, Du Boulay GH, Kakigi R, McDonald WI. Correlation of SEP abnormalities with brain and cervical cord MRI in multiple sclerosis. Brain 1991;114: 663-681
22. Larsson EM, Holtas S, Nilsson O. Gd-DTPA-enhanced MR in suspected spinal multiple sclerosis. AJNR 1989;10:1071-1076.
23. Kidd D, Thorpe JW, Thompson AJ, et al. Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 1993;43:2632-2637.
24. Wiebe S, Lee DH, Karlik SJ, et al. Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis. Ann Neurol 1992;32:643-650.
25. Kidd D, Thompson AJ, Kendall BE, Miller DH, McDonald WI. A serial MRI study of the brain and spinal cord in progressive multiple sclerosis [abstract]. J Neurol 1994;241(suppl 1):S151.
26. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
27. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability scale. Neurology 1983;33:1444-1452.
28. Bland JM, Altman DG. Statistic methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310.
29. Miller DH, Barkhof F, Nauta JJP. Gadolinium enhancement increased the sensitivity of MRI in detecting disease activity in multiple sclerosis. Brain 1993;116:1077-1094.
30. Grossman RI, Gonzales-Scarano F, Atlas SW, Galetta S, Silberberg DH. Multiple sclerosis: gadolinium enhancement in MR imaging. Radiology 1986;161:721-725.
31. Smith ME, Stone LA, Albert PS, et al. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. Ann Neurol 1993;33:480-489.
32. Thompson AJ, Miller D, Youl B, et al. Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration. Neurology 1992;42:60-63.
33. Matthews PM, Francis G, Antel J, Arnold DL. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis. Neurology 1991;41:1251-1226.
34. Davie CA, Hawkins CP, Barker GJ, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis. Brain 1994;117:49-58.
35. Dousset V, Grossman RI, Ramer KN, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992;182:483-491.
36. Gass A, Barker GJ, Kidd D, et al. Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Ann Neurol 1994;36:62-67.